IKS Inventurus Knowledge Solutions Q3 FY26 results (Oct–Dec 2025) and concall
IKS Health announced the strategic acquisition of TruBridge for $557 million, aiming to create a dominant integrated system of record and action in the rural hospital market. The combined entity reports pro forma revenue of $698 million and adjusted EBITDA of $186 million for calendar year 2025, with the deal being instantly EPS accretive. While management acknowledges initial high leverage and a multi-quarter integration period, they are confident in achieving INR 3,000 crores EBITDA by FY30 and significant deleveraging.
You’re reading a preview. Opening the full call uses 1 concall credit.
Sign in to use your monthly call allowance.
What they filed
Q3 FY26: revenue up 67.6%, net profit up 75.9% against the same quarter last year.
| Line item | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 | Q3 FY26 |
|---|---|---|---|---|---|---|
| Revenue | 240 | 241 | 290 | 319 | 356 +48% | 404 +68% |
| EBITDA | 116 | 103 | 129 | 150 | 178 +53% | 196 +90% |
| Net profit | 92 | 83 | 100 | 113 | 138 +50% | 146 +76% |
How to read this
₹ crore, as filed. The percentage beside a figure is the change against the same quarter a year earlier — never the quarter before, which would make every seasonal business look like it collapses and booms each year.
Inve summary of a publicly available earnings call transcript; see how call summaries are prepared. Not investment advice.
